0 patents currently held, every record listed here
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
This portfolio holds none of the 6 US patents in force on its record. from the record
Of the 6 now held by other companies, 4 were conveyed to Novartis AG in the filing they arrived in, and 2 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end
When these terms end
Each bar runs from grant to computed term end. 2024 to 2043.
US 12,679,834
7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof
May 25, 2042
US 12,441,737
Manufacture of Compounds and Compositions for Inhibiting the Activity of SHP2
Jun 10, 2042
US 12,774,275
Compounds and Compositions for the Treatment of Coronaviral Related Diseases
Jun 18, 2043
20282032203620402043
10 pending applications: term is not computable until grant.Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Jun 2043 · High confidence
Granted 2026. Too new for citation comparison; protection runs to 2043.
conveyed to Novartis AG
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
- Sep 29Assignment recorded on 1 record: Guo, Fengfeng to Suzhou Novartis Technical Development Co., Ltd., Recorded Sep 29, 2026, executed Mar 1, 2022. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76599, frame 957.
- 1 of the patents on this record was granted since Aug 19, 2026
Patents held now
Soonest term end first.
Also on record: 6 patents in force now held by others · 10 applications pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 computed term date comes from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.